Abbott | ABT - Stammkapital

Aktienkurs
100.62
Täglich Wechseln
-2.10 -2.04%
Monatlich
-8.73%
Jährlich
-20.70%
Q2 Prognose
99.77




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.7M 358K 2025-12
AtriCure USD 49.7M 10K 2025-09
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Boston Scientific USD 1.48B 1.46B 2025-06
Cooper Companies USD 195.1M 3.71M 2025-12
Danaher USD 706.9M 600K 2025-12
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Globus Medical USD 135.06M 449K 2025-12
Hologic USD 222.57M 350K 2025-09
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 354.5M 3.98M 2025-12
J&J USD 2.41B 584K 2025-09
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.29M 72K 2025-09
Pfizer USD 5.69B 1000K 2025-09
Smith & Nephew USD 875.96M 1.61M 2025-12
Solventum Corp USD 173.49M 51.34K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
Terumo JPY 1.48B 0 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12